Navigation Links
Reportlinker Adds Global Biometrics Industry
Date:10/18/2010

ystem 128

Voxeo Inks Partnership with VoiceVerified 129

Global Research Services Inks Strategic Alliance Deal with

CardioDynamics 129

Phoenix Technologies and Atmel to Create Advanced Security

Solutions 129

ImageWare Systems Signs Distribution Deal with iBilt 130

Lockheed Martin Inks Cooperation Deal with Cognitec 130

Validus Alliances with Integrated Microelectronics to Develop

Powered Card Solutions 130

Sanofi-Aventis Partners with SIBS and Expands R&D Facility 131

GTSI and Sagem Morpho Join Forces to Use PACS Integrated

Biometric Readers 131

BlueAnt Selects Sensory to Deploy Voice Control Equipped

Bluetooth Headset 132

CardinalCommerce forms Strategic Alliance with ip Capital Group 132

IdentiPHI Releases Biometric Security Solution for Enterprises 132

CIC and iPipeline Enters into Alliance for Electronic

Signature Platform to Insurance Carriers 133

CSC and CIC Forms Alliance to Offer Advanced eSignature

Solution for Banking Sector 133

CIC Partners 4Point to Offer Improved Financial Services

Solutions 134

Diaphonics Bags Secure Calling Platform Contract from Larimer

County 134

Ingram Micro Signs Distribution Agreement with FMA 135

SecuGen Collaborates with WCC over ELISE ID Platform 135

Sagem Securite Wins Albanian Contract for of Secure ID Document 136

Cogent Systems Secures Supply Contract for BlueCheck™ Devices

from LACRIS 136

Printrak Plans to Supply Bio-Enrol Stations to Norwegian

Public Agencies . 136

CMN Selects Biometric Fingerprint Readers of Sig-Tec and BIO-Key 137

McKesson Selects BIO-Key's WEB-Key Biometric Identification

Solution 137

SecuGen Corporation Collaborates with WCC Smart Search & Match 138

Visiphor Enters into a Contract with Austin Biometrics 138

LAN Gaming Chooses IdentiP
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related biology news :

1. Reportlinker Adds Carbon Dioxide Monitors Report
2. Reportlinker Adds World Dynamic Signature Verification Market Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Biomarkers - technologies, markets and companies
5. New studies find global warming will have significant economic impacts on Florida coasts
6. Growth in the global carbon budget
7. Global science community to gather in Mozambique
8. Experts to discuss global water crisis
9. World leaders in infectious diseases convene to discuss emerging global viruses
10. Mandate for biofuels production requires science-based policy and global perspective
11. 7 Texas mammals listed as threatened on Global Mammal Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... UPTON, NY - A study at the U.S. Department of ... "tagged" with a radioactive form of carbon can be used ... estrogen, in the human brain. The research, published in the ... regions of the brain where aromatase is concentrated may be ...
... breakthrough by scientists at the University of Sheffield has shed ... the land over 470 million years ago by forming a ... today (2 November 2010) in Nature Communications , has ... worked together with soil-dwelling fungi to ,green, the Earth in ...
... 2010 CONRAD, leaders in reproductive health and HIV prevention ... Agency for International Development (USAID). The grant will fund ... also prevent HIV and STI infections. USAID ... conducted by the Centre for Programme Research for AIDS in ...
Cached Biology News:PET scans reveal estrogen-producing hotspots in human brain 2Study shows how ancient plants and soil fungi turned the Earth green 2USAID awards $5 million to CONRAD 2
(Date:7/30/2015)... and Dallas, TX, USA (PRWEB) , ... July ... ... innovative nano and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. ... at executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Regional Cancer PatientsNEW ORLEANS, April 28 Ochsner Health ... Health Sciences Center , New Orleans ( www.lsuhsc.edu ... the region,s cancer patients by combining clinical care and ... and provide better access to care. This collaboration will ...
... could prove efficacious for both prophylactic and ... Corporation (NYSE AMEX: CVM ) ... that vaccines utilizing its proprietary L.E.A.P.S.(TM) (Ligand ... potentially induce protection against illnesses such as ...
... 28 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, announced today that results from a ... at the 12th Annual Conference on Vaccine Research, being ... is sponsored by the National Foundation of Infectious Diseases.David ...
Cached Biology Technology:Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 2PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 4PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 5PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 6PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 7
... KLH-conjugated, synthetic peptide corresponding to ... mouse p19ARF. The epitope ... 62-75. Clone 5-C3-1. Quality ... immunoblot. Stability ...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Complete cell culture media with cytokines...
...
Biology Products: